FXN and Friedreich ataxia: The amount of remaining frataxin in FRDA patients ranges from 30 to 2%, depending on the extent of the silencing that is linked to the number of GAA-triplet repeats (Campuzano et al., 1997; Lazaropoulos et al., 2015).